GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_37065/2025

Merz Therapeutics GmbH, Merz Pharma France, Merz Pharmaceuticals LLC

Datum
2025-09-17
Kammer
Paris (FR) Local Division
Verfahrensart
Generic application
Sprache
EN

Metadaten

Fall-IDORD_37065-2025-7db9108426aa
Aktenzeichen
RegisterzeichenORD_37065/2025
EntscheidungsreferenzORD_37065/2025
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 4

1 Paris Local Division UPC_CFI_697/2025 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 17/09/2025 APPLICANTS 1) Merz Therapeutics GmbH Eckenheimer Landstraße 100 60318 Frankfurt am Main - DE 2) Merz Pharmaceuticals LLC Unit 35/36, 6601 Six Forks Road, 4th Floor 27615 Raleigh, North Carolina - US 3) Merz Pharma France Tour EQHO, 2 Avenue Gambetta 92400 Courbevoie – FR Represented by Laëtitia Bénard RESPONDENT – DEFENDANT Viatris Santé 1 rue de Turin 69007 Lyon – FR Represented by Marc Lauzeral 2 PATENT AT ISSUE Patent no. Proprietor EP2377536 Merz Pharmaceuticals, LLC Patent no. SPC details EP2377536 SPC ID FR13C0033 National Designations FR Patent no. SPC ID National Designations Holders EP2377536 FR13C0033 FR Merz Pharmaceuticals, LLC COMPOSITION  ...